z-logo
open-access-imgOpen Access
Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy
Author(s) -
Elizabeth J. Sutton,
Lior Z. Braunstein,
Mahmoud ElTamer,
Edi Brogi,
Mary Hughes,
Yolanda Bryce,
Jill S. Gluskin,
Simon N. Powell,
Alyssa Woosley,
Audree B. Tadros,
Varadan Sevilimedu,
Danny F. Martinez,
Larowin Toni,
Olga Smelianskaia,
C. Gregory Nyman,
Pedram Razavi,
Larry Norton,
Maggie Fung,
James D. Sedorovich,
Virgilio Sacchini,
Elizabeth A. Morris
Publication year - 2021
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.34045
Subject(s) - medicine , breast cancer , magnetic resonance imaging , biopsy , interquartile range , neoadjuvant therapy , radiology , cancer , surrogate endpoint , stage (stratigraphy) , surgery , paleontology , biology
Key Points Question Is the accuracy of magnetic resonance imaging (MRI)–guided biopsy comparable with reference-standard surgical resection for diagnosing pathologic complete response after neoadjuvant chemotherapy in patients with breast cancer? Findings In this pilot nonrandomized controlled trial of 20 patients with evaluable data, the accuracy of MRI-guided biopsy for diagnosing pathologic complete response after neoadjuvant chemotherapy was 95% and the negative predictive value was 92.8%. Meaning The results from this pilot study suggest greater accuracy with this method than do the majority of published data and support the need for a larger study comparing MRI-guided biopsy with reference-standard surgical resection in diagnosing a pathologic complete response after neoadjuvant chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom